…has filed its audited financial results for the fiscal year ending May 31, 2021, the highlights of which are included in this news release.
today announced the results of the
antimicrobial efficacy test on a prototype of G6’s proprietary graphene-based air purifier (the
“Lab Test”) conducted by a US-based microbiological laboratory of The Intertek Group plc. The
test showed that the concentration of pathogenic microorganisms present in the testing chamber
was reduced by 99.9% (“Test Results”) over the duration of the experiment.
today announced the closing of the previously announced acquisition of all membership interests (the “Transaction”) of GX Technologies, LLC (“GX Technologies” or “GX”), effective August 25, 2021 (the “Closing Date”).
is pleased to announce that it has executed a definitive purchase agreement (the “Agreement”) to formalize and close the previously announced acquisition (the “Transaction”) of all membership interests of GX Technologies, LLC (“GX Technologies”). Pursuant to the terms of the Agreement, the consideration paid for the membership interests of GX Technologies is 25,000,000 common shares (the “Consideration Shares”) of G6 at a deemed price of C$0.20 per common share of the Company.
…is pleased to announce that it has filed its unaudited financial results for the third quarter of the fiscal year ending February 28, 2021, the highlights of which are included in this news release. The full set of Condensed Interim Consolidated Financial Statements and Management Discussion and Analysis can be viewed by visiting G6’s website at www.g6-materials.com or its profile page on SEDAR at www.sedar.com.
… is pleased to announce that it has entered into a letter agreement today, March 15, 2021, (the “LOI”) pursuant to which it intends to acquire all of the issued and outstanding shares of GX Technologies, Inc. (“GX Technologies”, the “Vendor”), in exchange for 25,000,000 common shares (the “Consideration Shares”) of G6 at a deemed price of $0.20 per common share of the Company (the “Transaction”). Simultaneously, the Company is pleased to announce a non-brokered equity financing to raise up to $5,000,000 through the offering of 25,000,000 units (the “Offering”). Each unit is priced at $0.20 and is comprised of one common share of the Company and one-half of one warrant to purchase a common share of the Company at a price of $0.30 for a period of 2 years from the closing date of the Offering.